Publications by authors named "Yasmin A Chandrasekher"
Article Synopsis
- Adalimumab-aqvh, also known as YUSIMRY, is a newly approved biosimilar to the original adalimumab by the FDA.
- The study aimed to evaluate the similarities between adalimumab-aqvh and the reference product by analyzing various structural and functional characteristics.
- Results showed that adalimumab-aqvh is structurally and functionally similar to adalimumab, with minimal differences that do not affect its efficacy, supporting its classification as a biosimilar.
Cytokines that signal through Class II receptors form a distinct family that includes the interferons and interleukin 10 (IL-10). Recent identification of several IL-10 homologs has defined a cytokine subfamily that includes AK155, IL-19, IL-20, IL-22, and IL-24. Within this subfamily, IL-19, IL-20, and IL-24 exhibit substantial sharing of receptor complexes; all three are capable of signaling through IL-20RA/IL-20RB, and IL-20 and IL-24 both can also use IL-22R/IL-20RB.
View Article and Find Full Text PDF